Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank93
3Y CAGR+5.6%
5Y CAGR+11.0%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+5.6%/yr
vs +16.1%/yr prior
5Y CAGR
+11.0%/yr
Recent deceleration
Acceleration
-10.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $14.34B | +1.0% |
| 2024 | $14.20B | +8.3% |
| 2023 | $13.12B | +7.8% |
| 2022 | $12.17B | -24.3% |
| 2021 | $16.07B | +89.1% |
| 2020 | $8.50B | +29.6% |
| 2019 | $6.56B | -2.3% |
| 2018 | $6.71B | +14.3% |
| 2017 | $5.87B | +20.8% |
| 2016 | $4.86B | - |